Compare NREF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NREF | OSUR |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.2M | 214.1M |
| IPO Year | N/A | 2000 |
| Metric | NREF | OSUR |
|---|---|---|
| Price | $12.84 | $2.94 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.50 | $3.00 |
| AVG Volume (30 Days) | 49.5K | ★ 484.0K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 15.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $24.65 | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $4.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.14 | $2.08 |
| 52 Week High | $16.80 | $4.22 |
| Indicator | NREF | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 27.38 | 47.96 |
| Support Level | $12.36 | $2.69 |
| Resistance Level | $15.25 | $2.99 |
| Average True Range (ATR) | 0.44 | 0.18 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 10.97 | 19.40 |
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.